A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients
- PMID: 31330810
- PMCID: PMC6682926
- DOI: 10.3390/nu11071662
A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients
Abstract
Patients with irritable bowel syndrome (IBS) exhibit low-grade inflammation and increased gut permeability. Dietary sugar has been shown to contribute to low-grade inflammation and increased gut permeability, and to correlate with gastrointestinal (GI) symptoms. The aim of the present study was to examine the effect of a starch- and sucrose-reduced diet (SSRD) on gastrointestinal (GI) and extra-intestinal symptoms in IBS. One hundred and five IBS patients (82 women, 46.06 ± 13.11 years), with irritable bowel syndrome-symptom severity scale (IBS-SSS) > 175, were randomized to SSRD for 4 weeks or continued ordinary eating habits. The visual analog scale for irritable bowel syndrome (VAS-IBS), IBS-SSS, and 4-day food diaries were collected at baseline and after 2 and 4 weeks. After the intervention, one-third of the patients did not fulfill the criteria for IBS/functional gastrointestinal disorder. Half of the participants changed from moderate/severe disease to no/mild disease according to IBS-SSS. Comparisons between the groups showed decreased weight and sweet cravings, and parallel decreases in total IBS-SSS and extra-intestinal IBS-SSS scores, in the intervention group compared to controls (p < 0.001 for all). When calculating separate extra-intestinal symptoms, belching (p = 0.001), muscle/joint pain (p = 0.029), urinary urgency (p = 0.017), and tiredness (p = 0.011) were decreased after introduction of SSRD compared to controls. In conclusion, SSRD improves both GI and extra-intestinal symptoms in IBS.
Keywords: diet; extra-intestinal symptoms; gastrointestinal symptoms; irritable bowel syndrome; starch; sucrose.
Conflict of interest statement
The authors have no conflict of interest.
Figures



Similar articles
-
Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients.Nutrients. 2019 Jun 5;11(6):1279. doi: 10.3390/nu11061279. Nutrients. 2019. PMID: 31195706 Free PMC article. Clinical Trial.
-
Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome.Nutrients. 2021 Jan 28;13(2):416. doi: 10.3390/nu13020416. Nutrients. 2021. PMID: 33525489 Free PMC article. Clinical Trial.
-
A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study.Nutrients. 2024 Sep 9;16(17):3039. doi: 10.3390/nu16173039. Nutrients. 2024. PMID: 39275354 Free PMC article. Clinical Trial.
-
Theories behind the effect of starch‑ and sucrose‑reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review).Mol Med Rep. 2021 Oct;24(4):732. doi: 10.3892/mmr.2021.12372. Epub 2021 Aug 20. Mol Med Rep. 2021. PMID: 34414452 Free PMC article. Review.
-
Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS.Best Pract Res Clin Gastroenterol. 2019 Jun-Aug;40-41:101607. doi: 10.1016/j.bpg.2019.03.003. Epub 2019 Apr 29. Best Pract Res Clin Gastroenterol. 2019. PMID: 31594647 Review.
Cited by
-
A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.Nutrients. 2022 Apr 19;14(9):1688. doi: 10.3390/nu14091688. Nutrients. 2022. PMID: 35565656 Free PMC article. Clinical Trial.
-
Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.BMC Gastroenterol. 2024 Sep 3;24(1):296. doi: 10.1186/s12876-024-03373-x. BMC Gastroenterol. 2024. PMID: 39227769 Free PMC article.
-
Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome.J Gastroenterol Hepatol. 2022 Jul;37(7):1253-1262. doi: 10.1111/jgh.15830. Epub 2022 Apr 5. J Gastroenterol Hepatol. 2022. PMID: 35304769 Free PMC article.
-
The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.J Clin Med. 2021 Oct 29;10(21):5077. doi: 10.3390/jcm10215077. J Clin Med. 2021. PMID: 34768601 Free PMC article. Review.
-
An Update on the Assessment and Management of Pediatric Abdominal Pain.Pediatric Health Med Ther. 2021 Aug 6;12:373-393. doi: 10.2147/PHMT.S287719. eCollection 2021. Pediatric Health Med Ther. 2021. PMID: 34393542 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources